The Capilano Honey Ltd share price just hit a 52-week low: Is it a buy?

The Capilano Honey Ltd (ASX:CZZ) share price has fallen to a 52-week low. Should you be snapping up the honey producer's shares today?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Unfortunately for its shareholders, the Capilano Honey Ltd (ASX: CZZ) share price tumbled to a 52-week low of $14.20 during trade today.

Following today's decline the leading honey producer's shares have now lost around a quarter of their value in the last six months.

Does this make it a buy?

While shares like Capilano Honey, Elders Ltd (ASX: ELD), and Select Harvests Limited (ASX: SHV) have a tendency to trade on lower-than-average multiples, at 13x trailing earnings I think the honey producer represents great value for money for investors.

Especially with the impressive progress the company has made with its exports into China. In its mixed half-year result a key highlight was the almost doubling of sales into the massive Chinese consumer market.

But the company isn't resting on its laurels there. Management is aiming to build on this early success with the launch of an               e-commerce website and accompanying social media marketing campaign.

In light of this I expect to see further sales growth in China in the second-half of the current fiscal year.

Further growth could come from its new product launches. Chief among them is its Beeotic prebiotic honey range which has been designed to boost digestive health. With the health and wellness market booming I believe this premium range could be particularly appealing to consumers that use honey for its supposed medicinal benefits.

All in all I believe the company has significant growth ahead of it over the next decade.

For this reason I think Capilano Honey could be a great buy and hold investment option for investors, especially with its shares trading at a 52-week low.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Capilano Honey Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »